Guardant Health (GH)
(Delayed Data from NSDQ)
$55.40 USD
+0.61 (1.11%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $56.09 +0.69 (1.25%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GH 55.40 +0.61(1.11%)
Will GH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GH
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
TMO Receives FDA Approval for Oncomine Dx Target Test
GH: What are Zacks experts saying now?
Zacks Private Portfolio Services
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
Other News for GH
NR7 appears for GH after 0.19% move
Guardant Health Director Makes Significant Stock Sale!
Insider Sell: Medina Hidalgo Sells 2,165 Shares of Guardant Health Inc (GH)
Guardant Health Expands Board, Appoints Alex Azar
The technical outlook for GH is unchanged after it falls 3.35% on September 12